Open AccessEvaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience
Author(s) -
Mozhdeh Momtahan,
Fatemeh Emami,
Fatemeh Sari Aslani,
Mojgan AkbarzadehJahromi
Publication year - 2020
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000188
Subject(s) - medicine , uterine sarcoma , endometrial stromal sarcoma , stage (stratigraphy) , radiation therapy , hazard ratio , leiomyosarcoma , sarcoma , mitotic index , oncology , single center , adjuvant therapy , survival rate , chemotherapy , surgery , pathology , paleontology , confidence interval , mitosis , biology , microbiology and biotechnology
Uterine sarcomas (US) constitute a rare heterogeneous group of gynecological malignancies with aggressive characteristics and poor prognosis. Identifying the histopathological factors that determine the prognosis of the tumor and efficacy of various treatment modalities provides a reliable source for efficient treatment of affected patients. This study presents our 11-year experience with US in the south of Iran.